Michael A. James

3.3k total citations
36 papers, 1.7k citations indexed

About

Michael A. James is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael A. James has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael A. James's work include RNA modifications and cancer (5 papers), RNA and protein synthesis mechanisms (4 papers) and Cancer-related molecular mechanisms research (3 papers). Michael A. James is often cited by papers focused on RNA modifications and cancer (5 papers), RNA and protein synthesis mechanisms (4 papers) and Cancer-related molecular mechanisms research (3 papers). Michael A. James collaborates with scholars based in United States, United Kingdom and China. Michael A. James's co-authors include Ming You, Aloysius J. Klingelhutz, John H. Lee, Haris G. Vikis, Susan Tsai, Michael B. Dwinell, Pengyuan Liu, Jill A. Gershan, Bryan Hunt and Bryon D. Johnson and has published in prestigious journals such as Nature Genetics, Blood and PLoS ONE.

In The Last Decade

Michael A. James

36 papers receiving 1.7k citations

Peers

Countries citing papers authored by Michael A. James

Since Specialization

Citations

This map shows the geographic impact of Michael A. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. James more than expected).

Fields of papers citing papers by Michael A. James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. James. The network helps show where Michael A. James may publish in the future.

Co-authorship network of co-authors of Michael A. James

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. James. A scholar is included among the top collaborators of Michael A. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. James. Michael A. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistance 2021 ·npj Precision Oncology ·Deepak Parashar, Anjali Geethadevi, Donna McAllister, Johnathan Ebben, Francis C. Peterson, Davin R. Jensen, Erin Bishop, Sunila Pradeep, Brian F. Volkman, Michael B. Dwinell, Pradeep Chaluvally–Raghavan, Michael A. James	23
2	p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis 2020 ·Cancer Research ·Fang Wang, Xiao-Mei Qi, (unknown), (unknown), Catherine E. Hagen, John Evans, Yuri Sheinin, Michael A. James, Pengyuan Liu, Susan Tsai, James P. Thomas, Alexander C. Mackinnon, Michael B. Dwinell, Charles R. Myers, Ramón Bartrons, Liwu Fu, Guan Chen	63
3	Racial Variation in Comfort Measures Only Status in Patients with Intracerebral Hemorrhage (S42.008) 2018 ·Neurology ·Cora Ormseth, Guido J. Falcone, Sara Jasak, David Mampre, Audrey C. Leasure, (unknown), David Y. Hwang, Michael A. James, Fernando D. Testai, Kyra J. Becker, David Tirschwell, Carl D. Langefeld, Daniel Woo, (unknown)	1
4	Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models 2018 ·BMC Cancer ·Susan Tsai, Laura McOlash, Katie Palen, Bryon D. Johnson, Christine Duris, Qiuhui Yang, Michael B. Dwinell, Bryan Hunt, Douglas B. Evans, Jill A. Gershan, Michael A. James	318
5	Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling 2016 ·Molecular Cancer Therapeutics ·László G. Puskás, (unknown), Gábor J. Szebeni, László Tiszlavicz, Susan Tsai, Michael A. James	16
6	A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression 2015 ·Anti-Cancer Drugs ·Michael A. James, William Seibel, Elena Kupert, Xiao Xuan Hu, (unknown), Marshall W. Anderson	3
7	CRR9/CLPTM1L Regulates Cell Survival Signaling and Is Required for Ras Transformation and Lung Tumorigenesis 2013 ·Cancer Research ·Michael A. James, Haris G. Vikis, Everett Tate, Amy L. Rymaszewski, Ming You	46
8	Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus 2012 ·PLoS ONE ·Michael A. James, Weidong Wen, Yian Wang, Lauren A. Byers, John V. Heymach, Kevin R. Coombes, Luc Girard, John D. Minna, Ming You	80
9	Principles for the post-GWAS functional characterization of cancer risk loci 2011 ·Nature Genetics ·Matthew L. Freedman, Álvaro N.A. Monteiro, Simon A. Gayther, Gerhard A. Coetzee, Angela Risch, Christoph Plass, Graham Casey, Mariella De Biasi, Chris Carlson, David Duggan, Michael A. James, Pengyuan Liu, Jay W. Tichelaar, Haris G. Vikis, Ming You, Ian G. Mills	298
10	Proline metabolism and cancer 2011 ·Frontiers in bioscience ·Michael A. James	93
11	Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis 2010 ·Molecular Carcinogenesis ·Michael A. James, (unknown), Yan Liu, Da‐Ren Chen, Ming You	72
12	Identification of Las2 , a Major Modifier Gene Affecting the Pas1 Mouse Lung Tumor Susceptibility Locus 2009 ·Cancer Research ·Peng-Yuan Liu, Haris G. Vikis, Michael A. James, Yan Lü, (unknown), Hong Bo Liu, (unknown), Yian Wang, Ming You	6
13	RGS17, an Overexpressed Gene in Human Lung and Prostate Cancer, Induces Tumor Cell Proliferation Through the Cyclic AMP-PKA-CREB Pathway 2009 ·Cancer Research ·Michael A. James, Yan Lü, Yan Liu, Haris G. Vikis, Ming You	86
14	Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor 2009 ·Oncogene ·Yan Lü, (unknown), Michael A. James, Haris G. Vikis, (unknown), Wen Wu, (unknown), Ming You	22
15	Common Human Cancer Genes Discovered by Integrated Gene-Expression Analysis 2007 ·PLoS ONE ·Yan Lü, Yijun Yi, Pengyuan Liu, Weidong Wen, Michael A. James, Daolong Wang, Ming You	68
16	HPV16‐E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300 2006 ·International Journal of Cancer ·Michael A. James, John H. Lee, Aloysius J. Klingelhutz	58
17	Age as a Predictive Factor of Mammographic Breast Density in Jamaican Women 2002 ·Clinical Radiology ·(unknown), Marvin Reid, Michael A. James	9
18	Dental and skeletal findings on an ancient Egyptian mummy 2000 ·American Journal of Orthodontics and Dentofacial Orthopedics ·(unknown), Samir E. Bishara, Michael A. James	15
19	Evaluation of Blood Cardioplegia Administration Systems 1985 ·Journal of ExtraCorporeal Technology ·(unknown), (unknown), (unknown), (unknown), (unknown), Michael A. James, Sheryl S. Smith, (unknown), (unknown), Anthony J. Tortólani, (unknown), (unknown)	2
20	Early Adolescent Ego Development 1980 ·The High School journal ·Michael A. James	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact